Join the conversation with our panel of Life Science Industry Leaders as they discuss CDMO challenges, opportunities and strategies in a COVID-19 World.
“Where are we going to meet between risk and addressing speed, flexibility and quality? How do we ensure that for our clients?” – Ann Flodin
“With this shift as a manufacturing partner, the level of trust and transparency expected by our customers will only intensify” – David Enloe
“We need to embrace diversity as part of our strategy; it starts with how we hire people, reaching out to communities to encourage people of different backgrounds to go into Life Sciences.” – Mark Bamforth
“What clients expect now from their CDMO is stability, consistency, reassurance, confidence, and execution; so they can worry about other priorities.” – Shailesh Maingi